Susquehanna International Group’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $175K | Buy |
245,206
+142,864
| +140% | +$102K | ﹤0.01% | 5632 |
|
2025
Q1 | $66.6K | Buy |
102,342
+28,873
| +39% | +$18.8K | ﹤0.01% | 5963 |
|
2024
Q4 | $135K | Sell |
73,469
-8,922
| -11% | -$16.4K | ﹤0.01% | 5536 |
|
2024
Q3 | $285K | Buy |
82,391
+19,861
| +32% | +$68.7K | ﹤0.01% | 4363 |
|
2024
Q2 | $183K | Buy |
62,530
+12,486
| +25% | +$36.6K | ﹤0.01% | 4805 |
|
2024
Q1 | $283K | Buy |
50,044
+12,807
| +34% | +$72.4K | ﹤0.01% | 4247 |
|
2023
Q4 | $160K | Sell |
37,237
-83,168
| -69% | -$357K | ﹤0.01% | 5121 |
|
2023
Q3 | $418K | Sell |
120,405
-14,578
| -11% | -$50.6K | ﹤0.01% | 3659 |
|
2023
Q2 | $628K | Sell |
134,983
-22,855
| -14% | -$106K | ﹤0.01% | 3326 |
|
2023
Q1 | $729K | Buy |
+157,838
| New | +$729K | ﹤0.01% | 3318 |
|
2022
Q4 | – | Sell |
-15,575
| Closed | -$86K | – | 6702 |
|
2022
Q3 | $86K | Sell |
15,575
-5,276
| -25% | -$29.1K | ﹤0.01% | 5332 |
|
2022
Q2 | $109K | Sell |
20,851
-22,053
| -51% | -$115K | ﹤0.01% | 4965 |
|
2022
Q1 | $353K | Buy |
42,904
+5,146
| +14% | +$42.3K | ﹤0.01% | 4150 |
|
2021
Q4 | $562K | Buy |
37,758
+8,376
| +29% | +$125K | ﹤0.01% | 3625 |
|
2021
Q3 | $555K | Sell |
29,382
-13,740
| -32% | -$260K | ﹤0.01% | 3549 |
|
2021
Q2 | $802K | Sell |
43,122
-23,453
| -35% | -$436K | ﹤0.01% | 3288 |
|
2021
Q1 | $1.52M | Buy |
+66,575
| New | +$1.52M | ﹤0.01% | 2432 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 5287 |
|